Pelthos Therapeutics Inc.
PTHS · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$16,238 | -$3,449 | -$1,968 | -$1,927 |
| Dep. & Amort. | $1,142 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $413 | $486 | $530 |
| Change in WC | -$5,033 | $2,424 | $755 | $650 |
| Other Non-Cash | $4,870 | $165 | $94 | $76 |
| Operating Cash Flow | -$15,259 | -$447 | -$632 | -$670 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $2,761 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $2,761 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$777 | $375 | $250 | -$154 |
| Stock Issued | $27,469 | $0 | $0 | $83 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $26,692 | $375 | $250 | -$71 |
| Forex Effect | -$73 | $0 | $0 | $0 |
| Net Chg. in Cash | $14,122 | -$72 | -$382 | -$741 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $131 | $131 | $513 | $1,255 |
| End Cash | $14,253 | $59 | $131 | $513 |
| Free Cash Flow | -$15,259 | -$447 | -$632 | -$670 |